Omnia SanaPlant Comparison
Purple coneflower vs Marjoram
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Purple coneflower and Marjoram: they share 5 indicated uses (arthritis / joint pain, infection (general), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Purple coneflower | Marjoram | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Infection (general) | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Lipophilic alkamides are considered key immunomodulatory and anti-inflammatory constituents, particularly concentrated in the root.
Antioxidant phenolic compounds contributing to the plant's immunomodulatory activity.
Water-soluble polysaccharides associated with immune-stimulating activity, particularly from the aerial parts.
The volatile oil, dominated by terpinen-4-ol and cis-sabinene hydrate in true sweet marjoram, gives most of the antimicrobial and antioxidant activity.
Contribute to antioxidant and anti-inflammatory activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally considered safe, but caution advised for those with autoimmune conditions. Not recommended for long-term use (more than 8 weeks continuously).
Duke (2002) rates echinacea as +++ — among the most thoroughly documented herbal immunostimulants. It notes experimental and clinical evidence for immunostimulant, antiviral, and anti-inflammatory activities. Multiple species have been studied (E. purpurea, E. angustifolia, E. pallida), and Duke emphasizes that species identification in commercial products is often unreliable. Commission E approves E. purpurea for supporting immune function during colds and flu. Dose: 900 mg standardized extract daily in acute use; use should be limited to 8 weeks continuous. Contraindicated in autoimmune diseases (MS, lupus, HIV/AIDS), tuberculosis, and with immunosuppressive drugs (cyclosporine) (Duke, 2002).
Generally very safe as a culinary herb. Essential oil should not be ingested in large amounts and avoided in pregnancy. Theoretically may interact with anticoagulants. Avoid medicinal doses during pregnancy.
Duke (2002) rates marjoram (Origanum majorana) as +++ and notes antiviral, antispasmodic, COX-2 inhibitory, and antiseptic activities at the experimental level (score 1). It demonstrates antiherpetic activity in vitro. The plant contains rosmarinic acid and thymol, which contribute to antioxidant and antimicrobial effects. Dose: 1–2 g dried herb as tea three times daily or equivalent preparations. Duke notes the plant is generally well-tolerated with no significant contraindications at usual herbal doses (Duke, 2002).
External Ids
Botanical Description
Robust perennial herb with a basal rosette of coarse, hairy, lance-shaped leaves and tall, sturdy flowering stems. Each stem bears a single large, daisy-like flower head with drooping (reflexed), rose-purple to pink ray florets surrounding a prominent, spiny, orange-brown central cone of disc florets.[4]
Tender perennial subshrub (Lamiaceae), often grown as an annual in cold climates, 20-60 cm tall, with square, downy, much-branched stems. Leaves are opposite, small, grey-green and ovate. Tiny white to pale pink, two-lipped flowers are borne in distinctive knot-like clustered spikes, the origin of the common name 'knotted marjoram'.[6]
Habitat
Native to the tallgrass prairies, open woodland and dry meadows of central and eastern North America; widely cultivated worldwide as a garden and medicinal plant.[4]
Native to Cyprus, Turkey and the eastern Mediterranean, and widely cultivated as a culinary and medicinal herb in gardens worldwide; prefers full sun and well-drained, often calcareous soils.[6]
Harvesting
The flower heads are picked as they open, in summer; the root is dug in autumn from plants at least two to three years old, when its content of bioactive alkamides and caffeic acid derivatives is highest, then cleaned and dried.[4]
The aerial flowering parts are cut just before or at flowering (summer), when essential-oil content is highest, and dried quickly in a warm, shaded, well-ventilated place.[9]
Traditional Uses
Echinacea root was widely used by Native American peoples as a remedy for infections, wounds, snakebite and toothache, and entered nineteenth-century Eclectic medicine as a broad anti-infective. It remains best known today, in standardised aerial-part or root extracts, as a supportive remedy for preventing and shortening the common cold and supporting immune function.[1, 4]
Marjoram has a long Mediterranean culinary-medicinal tradition as a digestive carminative and mild sedative for indigestion, cramping and poor sleep, and as an antiseptic for minor wounds and infections. Modern research confirms antispasmodic, antimicrobial, antioxidant and anti-inflammatory activity from its essential oil and phenolic constituents.[6, 8]
Preparations
Fresh-pressed juice or standardised extract of the aerial parts or root, taken as tablets, drops or capsules at the first sign of a cold; the best-studied clinical form.
Dosage
Clinical trials for the common cold commonly use around 300-900 mg of standardised extract daily, started at the first sign of symptoms and continued for up to 7-10 days; continuous use beyond about 8 weeks is not recommended. Educational reference only, not a prescription.
References
Drug Class Interactions
Lookalikes Review
References & Sources
- Karsch-Völk, M., Barrett, B., Kiefer, D., Bauer, R. et al (2014) 'Echinacea for preventing and treating the common cold', Cochrane Database of Systematic Reviews, 2(2), pp. CD000530. doi:10.1002/14651858.CD000530.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD000530.pub3 - Kamin, W., Seifert, G., Zwiauer, K., Bonhoeffer, J. et al (2025) 'Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review', Frontiers in Pediatrics, 13, pp. 1423250. doi:10.3389/fped.2025.1423250 Meta-analysis / review
https://doi.org/10.3389/fped.2025.1423250 - Fashner, J., Ericson, K. and Werner, S (2012) 'Treatment of the common cold in children and adults', American Family Physician, 86(2), pp. 153-159. Available at: https://pubmed.ncbi.nlm.nih.gov/22962927/ Traditional / reference
https://pubmed.ncbi.nlm.nih.gov/22962927/ - Manayi, A., Vazirian, M. and Saeidnia, S (2015) 'Echinacea purpurea: Pharmacology, phytochemistry and analysis methods', Pharmacognosy Reviews, 9(17), pp. 63-72. doi:10.4103/0973-7847.156353 Meta-analysis / review
https://doi.org/10.4103/0973-7847.156353 - Burlou-Nagy, C., Banica, F., Jurca, T., Vicas, L.G., Marian, E., Muresan, M.E., Bacskay, I., Kiss, R., Feher, P. and Pallag, A (2022) 'Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review', Plants, 11(9), pp. 1244. doi:10.3390/plants11091244 Meta-analysis / review
https://doi.org/10.3390/plants11091244 - Hall, H., Fahlman, M.M. and Engels, H.J (2007) 'Echinacea purpurea and mucosal immunity', International Journal of Sports Medicine, 28(9), pp. 792-797. doi:10.1055/s-2007-964895 Randomized trial
https://doi.org/10.1055/s-2007-964895 - Ross, S.M (2016) 'Echinacea purpurea: A Proprietary Extract of Echinacea purpurea Is Shown to be Safe and Effective in the Prevention of the Common Cold', Holistic Nursing Practice, 30(1), pp. 54-57. doi:10.1097/HNP.0000000000000130 Meta-analysis / review
https://doi.org/10.1097/HNP.0000000000000130 - Hudson, J.B (2011) 'Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases', Journal of Biomedicine & Biotechnology, 2012, pp. 769896. doi:10.1155/2012/769896 Meta-analysis / review
https://doi.org/10.1155/2012/769896 - Mishima, S., Saito, K., Maruyama, H., Inoue, M., Yamashita, T., Ishida, T. and Gu, Y (2004) 'Antioxidant and immuno-enhancing effects of Echinacea purpurea', Biological & Pharmaceutical Bulletin, 27(7), pp. 1004-1009. doi:10.1248/bpb.27.1004 Preclinical
https://doi.org/10.1248/bpb.27.1004 - Saunders, P.R., Smith, F. and Schusky, R.W (2007) 'Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections', Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1195-1199. doi:10.1139/Y07-103 Clinical study
https://doi.org/10.1139/Y07-103 - Micheli, L., Maggini, V., Ciampi, C., Gallo, E., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Di Cesare Mannelli, L., De Leo, M. and Firenzuoli, F (2022) 'Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy', Phytotherapy Research, 37(5), pp. 1911-1923. doi:10.1002/ptr.7709 Preclinical
https://doi.org/10.1002/ptr.7709 - Gholami, M., Amri, J., Pazhoohan, S. and Sadegh, M (2021) 'Anticonvulsive and anti-epileptogenesis effects of Echinacea purpurea root extract, an involvement of CB2 receptor', Journal of Complementary & Integrative Medicine, 19(4), pp. 879-886. doi:10.1515/jcim-2020-0219 Preclinical
https://doi.org/10.1515/jcim-2020-0219 - Awortwe, C., Bruckmueller, H., Kaehler, M. and Cascorbi, I (2021) 'Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters', Molecular Pharmaceutics, 18(4), pp. 1622-1633. doi:10.1021/acs.molpharmaceut.0c01075 Preclinical
https://doi.org/10.1021/acs.molpharmaceut.0c01075 - Perry, N.B., van Klink, J.W., Burgess, E.J. and Parmenter, G.A (1997) 'Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers', Planta Medica, 63(1), pp. 58-62. doi:10.1055/s-2006-957605 Preclinical
https://doi.org/10.1055/s-2006-957605 - Linde, K., Barrett, B., Wölkart, K., Bauer, R. and Melchart, D (2006) 'Echinacea for preventing and treating the common cold'. Traditional / reference
https://scholar.google.com/scholar?q=Echinacea%20for%20preventing%20and%20treating%20the%20common%20cold - Sharma, M., Schoop, R., Suter, A. and Schoop, W (2010) 'The possibility of prophylactic treatment of streptococcal pharyngotonsillitis with a standardized Echinacea preparation', 29(8), pp. 1025--1035. Traditional / reference
https://scholar.google.com/scholar?q=The%20possibility%20of%20prophylactic%20treatment%20of%20streptococcal%20pharyngotonsillitis%20with%20a%20standardized%20Echinacea%20preparation - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Gorski, J.C., Huang, S.M., Pinto, A., Hamman, M.A., Hilligoss, J.K., Zaheer, N.A., Desai, M., Miller, M. and Hall, S.D (2004) 'The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo', Clinical Pharmacology and Therapeutics, 75(1), pp. 89-100. doi:10.1016/j.clpt.2003.09.013 Clinical study
https://doi.org/10.1016/j.clpt.2003.09.013
- Rehman, N.U., Ansari, M.N., Ahmad, W. and Ali, A (2024) 'Calcium Channel Inhibitory Effect of Marjoram (Origanum majorana L.): Its Medicinal Use in Diarrhea and Gut Hyperactivity', Frontiers in Bioscience (Landmark Edition), 29(2), pp. 47. doi:10.31083/j.fbl2902047 Preclinical
https://doi.org/10.31083/j.fbl2902047 - Hussein, Z. and Yasir, S.M (2022) 'Origanum majorana attenuates ciprofloxacin-induced nephropathy in rats', Wiadomosci Lekarskie, 75(12), pp. 3046-3049. doi:10.36740/WLek202212126 Preclinical
https://doi.org/10.36740/WLek202212126 - Elfiky, A.M., Ibrahim, R.S., Khattab, A.R., Kadry, M.O. and others (2025) 'Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: insights from serum metabolomics, network pharmacology and experimental validation', BMC Complementary Medicine and Therapies, 25(1), pp. 67. doi:10.1186/s12906-025-04774-5 Preclinical
https://doi.org/10.1186/s12906-025-04774-5 - Waller, S.B., Cleff, M.B., de Mattos, C.B., da Silva, C.C. and others (2021) 'Protection of the marjoram (Origanum majorana Linn.) essential oil in cutaneous sporotrichosis caused by Sporothrix brasiliensis', Natural Product Research, 35(17), pp. 2977-2981. doi:10.1080/14786419.2019.1678617 Preclinical
https://doi.org/10.1080/14786419.2019.1678617 - Haj-Husein, I., Tukan, S. and Alkazaleh, F (2016) 'The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study', Journal of Human Nutrition and Dietetics, 29(1), pp. 105-111. doi:10.1111/jhn.12290 Randomized trial
https://doi.org/10.1111/jhn.12290 - Bouyahya, A., Chamkhi, I., Benali, T., Guaouguaou, F.E. and others (2021) 'Traditional use, phytochemistry, toxicology, and pharmacology of Origanum majorana L', Journal of Ethnopharmacology, 265, pp. 113318. doi:10.1016/j.jep.2020.113318 Meta-analysis / review
https://doi.org/10.1016/j.jep.2020.113318 - Al-Howiriny, T., Alsheikh, A., Alqasoumi, S., Al-Yahya, M. and others (2009) 'Protective Effect of Origanum majorana L. 'Marjoram' on various models of gastric mucosal injury in rats', The American Journal of Chinese Medicine, 37(3), pp. 531-545. doi:10.1142/S0192415X0900703X Preclinical
https://doi.org/10.1142/S0192415X0900703X - Bina, F. and Rahimi, R (2017) 'Sweet Marjoram: A Review of Ethnopharmacology, Phytochemistry, and Biological Activities', Journal of Evidence-Based Complementary & Alternative Medicine, 22(1), pp. 175-185. doi:10.1177/2156587216650793 Meta-analysis / review
https://doi.org/10.1177/2156587216650793 - Paudel, P.N., Satyal, P., Satyal, R., Setzer, W.N. and others (2022) 'Chemical Composition, Enantiomeric Distribution, Antimicrobial and Antioxidant Activities of Origanum majorana L. Essential Oil from Nepal', Molecules, 27(18), pp. 6136. doi:10.3390/molecules27186136 Preclinical
https://doi.org/10.3390/molecules27186136 - Makrane, H., Aziz, M., Mekhfi, H., Ziyyat, A. and others (2019) 'Origanum majorana L. extract exhibit positive cooperative effects on the main mechanisms involved in acute infectious diarrhea', Journal of Ethnopharmacology, 239, pp. 111503. doi:10.1016/j.jep.2018.09.005 Preclinical
https://doi.org/10.1016/j.jep.2018.09.005 - Baser, K.H.C (2008) 'Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils', 14(29), pp. 3106--3119. doi:10.2174/138161208786404227 Traditional / reference
https://doi.org/10.2174/138161208786404227 - Hoffmann, D (2003) 'Medical Herbalism'. Traditional / reference
https://scholar.google.com/scholar?q=Medical%20Herbalism - Seidler-Lozykowska, K. et al (2016) 'Essential oil content and composition of sweet marjoram (Origanum majorana L.) grown in Poland', 62(1), pp. 37--45. Traditional / reference
https://scholar.google.com/scholar?q=Essential%20oil%20content%20and%20composition%20of%20sweet%20marjoram%20%28Origanum%20majorana%20L.%29%20grown%20in%20Poland - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.